GGHC
ARVN icon

Gilder Gagnon Howe & Co’s Arvinas ARVN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-99,271
Closed -$731K – 252
2025
Q2 		$731K Sell
99,271
-91,311
-48% -$673K 0.01% 211
2025
Q1 		$1.34M Buy
190,582
+3,988
+2% +$62.5K 0.02% 180
2024
Q4 		$3.58M Sell
186,594
-7,749
-4% -$188K 0.04% 162
2024
Q3 		$4.79M Sell
194,343
-90,756
-32% -$2.37M 0.06% 150
2024
Q2 		$7.59M Sell
285,099
-39,745
-12% -$1.27M 0.1% 121
2024
Q1 		$13.4M Sell
324,844
-8,680
-3% -$379K 0.17% 106
2023
Q4 		$13.7M Buy
333,524
+162,674
+95% +$3.8M 0.19% 101
2023
Q3 		$3.36M Sell
170,850
-224,383
-57% -$5.5M 0.05% 160
2023
Q2 		$9.81M Buy
395,233
+15,514
+4% +$399K 0.13% 119
2023
Q1 		$10.4M Sell
379,719
-86,870
-19% -$2.74M 0.17% 103
2022
Q4 		$16M Sell
466,589
-215,142
-32% -$9.05M 0.3% 86
2022
Q3 		$30.3M Sell
681,731
-39,274
-5% -$1.91M 0.53% 53
2022
Q2 		$30.3M Sell
721,005
-638,804
-47% -$32.1M 0.54% 54
2022
Q1 		$91.5M Sell
1,359,809
-175,491
-11% -$12M 0.85% 35
2021
Q4 		$126M Buy
1,535,300
+8
+0% +$651 0.72% 44
2021
Q3 		$126M Sell
1,535,292
-5,599
-0.4% -$495K 0.65% 51
2021
Q2 		$119M Sell
1,540,891
-47,637
-3% -$3.31M 0.58% 52
2021
Q1 		$105M Sell
1,588,528
-167,594
-10% -$12.8M 0.57% 54
2020
Q4 		$149M Buy
1,756,122
+430,862
+33% +$14.9M 0.74% 33
2020
Q3 		$31.3M Sell
1,325,260
-111,344
-8% -$3.23M 0.19% 112
2020
Q2 		$48.2M Sell
1,436,604
-139,668
-9% -$5.93M 0.38% 77
2020
Q1 		$63.5M Buy
+1,576,272
New +$73.7M 0.76% 43
2018
Q4 		– Sell
-7,653
Closed -$129K – 268
2018
Q3 		$129K Buy
+7,653
New +$126K ﹤0.01% 270

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Gilder Gagnon Howe & Co's ARVN Position: Q3 2025 in Review

Gilder Gagnon Howe & Co sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 99,271 shares — an estimated $731K sold.

Gilder Gagnon Howe & Co first reported a position in ARVN in Q3 2018 and held it in 23 quarters. The position peaked at $149M in Q4 2020. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

  • Gilder Gagnon Howe & Co reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 99,271 Arvinas shares in Q3 2025, an estimated $731K.
  • Gilder Gagnon Howe & Co first reported a position in Arvinas in Q3 2018 and held it in 23 quarters.
  • Gilder Gagnon Howe & Co's Arvinas position peaked at $149M in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2025, filed 14 Nov 2025.